I received The PSBJ in the mail Thursday...
people may have got around to reading their
copy this weekend, so you may see strength in
the stock today. A blurb in the Seattle Times
would really do the trick--you may remember that
pop a few months ago in TGEN's stock after a full
page article ran in the Sunday edition.
Apparently the small biotech stocks have been
ignored for so long that they are increasingly
having to look for infusions of private funds.
It's a real shame for investors who are holding
out, hoping the sector will perk up when suddenly
something like a toxic convertible goes through.
Recently a very small company in which I have shares
received 1/4M from some wealthy dude who used to be
management at Intel. He got a pretty good deal, a
discount to the current market price. But you could
argue that even the current market price was way
too cheap--I say let them buy their shares in the
market (but the company needed some cash, etc etc,
so what can you do?)
But enough of that, getting back to small companies
which are oriented toward cancer. I recently got into
MAGN and ONXX, and there are plenty of good bets out
there, tell me what they are and I'll swap my ideas
for others in a heartbeat...for now, Magainin and
Onyx were the best I could find for the price. BIOM
has a cancer vaccine, that might be an interesting
company. I'm always looking for other suggestions--SUGN,
CELG, MOGN, and IMCL would be the more obvious choices
right now.
Please come by the thread if you spot any ideas...
Subject 27352 |
